SK284337B6 - Kombinácia fixných dávok inhibítora enzýmu konvertujúceho angiotenzín a antagonistu vápnikového kanálu, jej použitie, farmaceutická kompozícia na báze tejto kombinácie a spôsob jej výroby - Google Patents

Kombinácia fixných dávok inhibítora enzýmu konvertujúceho angiotenzín a antagonistu vápnikového kanálu, jej použitie, farmaceutická kompozícia na báze tejto kombinácie a spôsob jej výroby Download PDF

Info

Publication number
SK284337B6
SK284337B6 SK616-98A SK61698A SK284337B6 SK 284337 B6 SK284337 B6 SK 284337B6 SK 61698 A SK61698 A SK 61698A SK 284337 B6 SK284337 B6 SK 284337B6
Authority
SK
Slovakia
Prior art keywords
dose
nitrendipine
enalapril
combination
agent
Prior art date
Application number
SK616-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK61698A3 (en
Inventor
Soler Pedro C�Novas
Duarte Joaquin Delgadillo
Escuder Lu�S Manuel Micheto
Original Assignee
Procter & Gamble Pharmaceuticals S.A.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8299270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284337(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble Pharmaceuticals S.A.R.L. filed Critical Procter & Gamble Pharmaceuticals S.A.R.L.
Publication of SK61698A3 publication Critical patent/SK61698A3/sk
Publication of SK284337B6 publication Critical patent/SK284337B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SK616-98A 1997-05-13 1998-05-11 Kombinácia fixných dávok inhibítora enzýmu konvertujúceho angiotenzín a antagonistu vápnikového kanálu, jej použitie, farmaceutická kompozícia na báze tejto kombinácie a spôsob jej výroby SK284337B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701017A ES2125198B1 (es) 1997-05-13 1997-05-13 Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.

Publications (2)

Publication Number Publication Date
SK61698A3 SK61698A3 (en) 1998-12-02
SK284337B6 true SK284337B6 (sk) 2005-02-04

Family

ID=8299270

Family Applications (1)

Application Number Title Priority Date Filing Date
SK616-98A SK284337B6 (sk) 1997-05-13 1998-05-11 Kombinácia fixných dávok inhibítora enzýmu konvertujúceho angiotenzín a antagonistu vápnikového kanálu, jej použitie, farmaceutická kompozícia na báze tejto kombinácie a spôsob jej výroby

Country Status (23)

Country Link
EP (1) EP0884054B9 (es)
JP (1) JP3576806B2 (es)
CN (1) CN1146418C (es)
AR (1) AR011730A1 (es)
AT (1) ATE236653T1 (es)
AU (1) AU735404B2 (es)
BR (1) BR9805597A (es)
CA (1) CA2234899C (es)
CZ (1) CZ292616B6 (es)
DE (1) DE69813083T2 (es)
DK (1) DK0884054T3 (es)
ES (2) ES2125198B1 (es)
HU (1) HUP9801075A3 (es)
IL (1) IL124253A (es)
NO (1) NO315545B1 (es)
NZ (1) NZ330447A (es)
PL (1) PL192117B1 (es)
PT (1) PT884054E (es)
RU (1) RU2182002C2 (es)
SK (1) SK284337B6 (es)
TR (1) TR199800847A2 (es)
TW (1) TW562679B (es)
ZA (1) ZA983806B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
EP1285655B1 (en) * 2000-04-11 2007-05-30 Sankyo Company, Limited Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine
SK287988B6 (sk) * 2001-01-26 2012-09-03 Schering Corporation Composition, oral dosage form and use thereof
WO2004054574A1 (ja) * 2002-12-16 2004-07-01 Kissei Pharmaceutical Co., Ltd. 経口固形医薬
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法
CN109985013B (zh) * 2019-05-10 2021-08-10 河北君圣药业有限公司 一种尼群地平分散片及其制备方法
CN115501224A (zh) * 2022-10-09 2022-12-23 南昌大学第一附属医院 马来酸依那普利叶酸片联合通心络在制备治疗高血压合并颈动脉硬化药物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
YU48602B (sh) * 1991-11-25 1998-12-23 Krka Tovarna Zdravil P.O. Postupak za dobijanje stabilne formulacije soli enalaprila
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
TR199800847A3 (tr) 1999-10-21
ATE236653T1 (de) 2003-04-15
CZ138198A3 (cs) 1998-12-16
CZ292616B6 (cs) 2003-11-12
BR9805597A (pt) 2000-04-11
TW562679B (en) 2003-11-21
CA2234899C (en) 2004-08-10
ES2197443T3 (es) 2004-01-01
NZ330447A (en) 1998-12-23
EP0884054A2 (en) 1998-12-16
DE69813083T2 (de) 2004-05-27
AR011730A1 (es) 2000-08-30
RU2182002C2 (ru) 2002-05-10
JPH11124330A (ja) 1999-05-11
AU735404B2 (en) 2001-07-05
EP0884054A3 (en) 2000-08-23
IL124253A (en) 2003-01-12
CN1212869A (zh) 1999-04-07
HU9801075D0 (en) 1998-07-28
ES2125198B1 (es) 1999-11-16
NO315545B1 (no) 2003-09-22
DK0884054T3 (da) 2003-07-21
DE69813083D1 (de) 2003-05-15
EP0884054B9 (en) 2007-02-14
CA2234899A1 (en) 1998-11-13
HUP9801075A2 (hu) 1999-01-28
SK61698A3 (en) 1998-12-02
HUP9801075A3 (en) 2000-12-28
PT884054E (pt) 2003-08-29
PL326246A1 (en) 1998-11-23
AU6597398A (en) 1998-11-19
NO982112D0 (no) 1998-05-08
PL192117B1 (pl) 2006-09-29
JP3576806B2 (ja) 2004-10-13
EP0884054B1 (en) 2003-04-09
TR199800847A2 (xx) 1999-10-21
ZA983806B (en) 1999-02-19
CN1146418C (zh) 2004-04-21
NO982112L (no) 1998-11-16
ES2125198A1 (es) 1999-02-16

Similar Documents

Publication Publication Date Title
CA2174338C (en) Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
JP2004516266A (ja) アムロジピンおよびベナゼブリルの治療的組み合わせ
Sever Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.
US20080268049A1 (en) Stable Solid Dosage Forms of Amlodipine and Benazepril
SK284337B6 (sk) Kombinácia fixných dávok inhibítora enzýmu konvertujúceho angiotenzín a antagonistu vápnikového kanálu, jej použitie, farmaceutická kompozícia na báze tejto kombinácie a spôsob jej výroby
JPH03153633A (ja) ２型糖尿病の予防用薬剤
KR100708560B1 (ko) 미르타자핀을 포함한 경구 붕해성 조성물
HU205714B (en) Process for producing hypotensive pharmaceutical compositions by using combination of angiotensin converting enzyme inhibitors and potassium canal modulator
HU219447B (hu) Eljárás ACE-gátlót és kalcium-antagonistát tartalmazó proteinuria megelőzésére és kezelésére alkalmas gyógyszerkészítmény előállítására, és trandozaprilt és verapamilt tartalmazó gyógyszerkészítmény
EP0336950B1 (en) Potentiation of antihypertensive effect of ace inhibitors
WO1998015290A1 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-CoA REDUCTASE INHIBITORS, IN PARTICULAR FLUVASTATIN
MXPA98003747A (es) Asociación a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparación y su utilización para el tratamiento de enfermedades cardiovasculares
WO2008068577A2 (en) Pharmaceutical compositions
US20040048905A1 (en) Therapeutic combination of amlodipine and benazepril
US20080287412A1 (en) Therapeutic combination of amlodipine and benazepril/benazeprilat
SA98190540B1 (ar) جرعة مشتركة ثابتة تحتوي على مثبط لأنزيم تحويل الأنجيوتنسين وعلى عامل مضاد لقناة الكالسيوم لعلاج الأمراض القلبية الوعائية

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: FERRER INTERNACIONAL, S.A., BARCELONA, ES

Free format text: FORMER OWNER: PROCTER & GAMBLE PHARMACEUTICALS S.A.R.L., PETIT- LANCY, CH

Effective date: 20080430

MK4A Patent expired

Expiry date: 20180511